Center for Scientific Review; Notice of Closed Meetings, 26106 [06-4148]
Download as PDF
26106
Federal Register / Vol. 71, No. 85 / Wednesday, May 3, 2006 / Notices
Name of Committee: Oncological Sciences
Integrated Review Group, Chemo/Dietary
Prevention Study Section.
Date: June 14–16, 2006
Time: 5 p.m to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington Embassy Row,
2015 Massachusetts Ave., NW., Washington,
DC 20036.
Contact Person: Sally A. Mulhern, PhD.,
Scientific Review Administrator, Center For
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6198,
MSC 7804, Bethesda, MD 20892, (301) 435–
5877, mulherns@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos.; 93.306, Comparative
Medicine; 93.333, Clinical Research; 93.306,
93.333, 93.337, 93.393–93.396, 93.837–
93.844, 93.846–93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: April 25, 2006.
David Clary,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–4147 Filed 5–2–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
jlentini on PROD1PC65 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Fellowship.
Date: May 3, 2006.
Time: 2 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Michael Micklin, PhD,
Chief, RPHB IRG, Center for Scientific
Review, National Institutes of Health, 6701
Rockledge Drive, Room 3136, MSC 7759,
Bethesda, MD 20892, (301) 435–1258,
micklinm@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
VerDate Aug<31>2005
19:53 May 02, 2006
Jkt 208001
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Prion
Disease Regulation and Diagnostics.
Date: May 4, 2006.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Richard G. Kostriken, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3192,
MSC 7808, Bethesda, MD 20892, 301–402–
4454, kostrikr@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Bioengineering Research Partnership.
Date: May 19, 2006.
Time: 2 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Pushpa Tandon, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5104,
MSC 7854, Bethesda, MD 20892, 301–435–
2397, tandonp@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: BMIT and MEDI Study Sections.
Date: May 21, 2006.
Time: 7 p.m. to 10 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Silver Spring, 8727 Colesville
Road, Silver Spring, MD 20910.
Contact Person: Weihua Luo, MD, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5114,
MSC 7854, Bethesda, MD 20892, (301) 435–
1170, luow@csr.nih.gov.
Name of Committee: Cardiovascular
Sciences Integrated Review Group,
Cardiovascular Differentiation and
Development Study Section.
Date: June 12–13, 2006.
Time: 8:30 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Maqsood A. Wani, PhD,
DVM, Scientific Review Administrator,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 2114, MSC 7814, Bethesda, MD 20892,
(301) 435–2270, wanimaqs@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Social
Science and Population Studies RO3s, R15s,
R21s and Fellowships.
Date: June 16, 2006.
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Valerie Durrant, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3148,
MSC 7770, Bethesda, MD 20892, (301) 435–
3554, durrantv@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos.; 93.306, Comparative
Medicine; 93.333, Clinical Research; 93.306,
93.333, 93.337, 93.393–93.396, 93.837–
93.844, 93.846–93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: April 25, 2006.
David Clary,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–4148 Filed 5–2–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Revocation of Certification of a
Laboratory Which No Longer Meets
Minimum Standards To Engage in
Urine Drug Testing for Federal
Agencies
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice.
AGENCY:
SUMMARY: The Department of Health and
Human Services routinely publishes a
list of laboratories in the Federal
Register that are currently certified to
meet standards of Subpart C of the
Mandatory Guidelines for Federal
Workplace Drug Testing Programs
(Mandatory Guidelines). The Mandatory
Guidelines were first published in the
Federal Register on April 11, 1988 (53
FR 11970), and subsequently revised in
the Federal Register on June 9, 1994 (59
FR 29908), on September 30, 1997 (62
FR 51118), and on April 13, 2004 (69 FR
19644).
This notice informs the public that
the following laboratory’s certification
was revoked effective February 8, 2006:
Sciteck Clinical Laboratories, Inc., 317
Rutledge Road, Fletcher, North Carolina
28732.
The letter describing the reasons for
revoking Sciteck’s certification is
available on the Internet at https://
workplace.samhsa.gov.
FOR FURTHER INFORMATION CONTACT: Dr.
Donna Bush, Division of Workplace
Programs, SAMHSA/CSAP, Room
\\ALPHA3\E\FR\FM\03MYN1.SGM
03MYN1
Agencies
[Federal Register Volume 71, Number 85 (Wednesday, May 3, 2006)]
[Notices]
[Page 26106]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-4148]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel Fellowship.
Date: May 3, 2006.
Time: 2 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Michael Micklin, PhD, Chief, RPHB IRG, Center
for Scientific Review, National Institutes of Health, 6701 Rockledge
Drive, Room 3136, MSC 7759, Bethesda, MD 20892, (301) 435-1258,
micklinm@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel Prion Disease Regulation and Diagnostics.
Date: May 4, 2006.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Richard G. Kostriken, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3192, MSC 7808, Bethesda, MD
20892, 301-402-4454, kostrikr@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to timing limitations imposed by the review and funding
cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Bioengineering Research Partnership.
Date: May 19, 2006.
Time: 2 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Pushpa Tandon, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5104, MSC 7854, Bethesda, MD
20892, 301-435-2397, tandonp@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Member Conflict: BMIT and MEDI Study Sections.
Date: May 21, 2006.
Time: 7 p.m. to 10 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Silver Spring, 8727 Colesville Road, Silver
Spring, MD 20910.
Contact Person: Weihua Luo, MD, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5114, MSC 7854, Bethesda, MD
20892, (301) 435-1170, luow@csr.nih.gov.
Name of Committee: Cardiovascular Sciences Integrated Review
Group, Cardiovascular Differentiation and Development Study Section.
Date: June 12-13, 2006.
Time: 8:30 a.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: Gaithersburg Marriott Washingtonian Center, 9751
Washingtonian Boulevard, Gaithersburg, MD 20878.
Contact Person: Maqsood A. Wani, PhD, DVM, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2114, MSC 7814, Bethesda, MD
20892, (301) 435-2270, wanimaqs@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Social Science and Population Studies RO3s, R15s, R21s and
Fellowships.
Date: June 16, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road, NW., Washington, DC 20015.
Contact Person: Valerie Durrant, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3148, MSC 7770, Bethesda, MD
20892, (301) 435-3554, durrantv@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos.; 93.306,
Comparative Medicine; 93.333, Clinical Research; 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: April 25, 2006.
David Clary,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-4148 Filed 5-2-06; 8:45 am]
BILLING CODE 4140-01-M